Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma宣布 SPC-15 的鼻内分娩显示 “快速有效” 的创伤后应激障碍疗法药物敞口，此后，Silo Pharma的股价走高。
Silo Pharma Shares Are Trading Higher After the Company Announced Intranasal Delivery of SPC-15 Showed a 'Rapid and Effective' Drug Exposure for PTSD Therapy.
Silo Pharma宣布 SPC-15 的鼻内分娩显示 “快速有效” 的创伤后应激障碍疗法药物敞口，此后，Silo Pharma的股价走高。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。